Taro Shibata

Taro Shibata

UNVERIFIED PROFILE

Are you Taro Shibata?   Register this Author

Register author
Taro Shibata

Taro Shibata

Publications by authors named "Taro Shibata"

Are you Taro Shibata?   Register this Author

73Publications

1114Reads

40Profile Views

Antimicrobial prophylaxis for 1 day versus 3 days in liver cancer surgery: a randomized controlled non-inferiority trial.

Surg Today 2019 Oct 27;49(10):859-869. Epub 2019 Apr 27.

Chairman of the Board of Directors, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8510, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00595-019-01813-wDOI Listing
October 2019

Development of a real-time endoscopic image diagnosis support system using deep learning technology in colonoscopy.

Sci Rep 2019 Oct 8;9(1):14465. Epub 2019 Oct 8.

Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-50567-5DOI Listing
October 2019

Phase III study of watchful waiting vs. rituximab as first-line treatment in advanced stage follicular lymphoma with low tumour burden (JCOG1411, FLORA study).

Jpn J Clin Oncol 2018 Aug;48(8):777-780

Department of Hematology and Oncology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyy085DOI Listing
August 2018

Utility of Bayesian Single-Arm Design in New Drug Application for Rare Cancers in Japan: A Case Study of Phase 2 Trial for Sarcoma.

Ther Innov Regul Sci 2018 05 8;52(3):334-338. Epub 2017 Sep 8.

2 Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2168479017728989DOI Listing
May 2018

A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413).

Jpn J Clin Oncol 2018 Feb;48(2):190-194

Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine Hiroshima University, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyx170DOI Listing
February 2018

Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1.

Cancer Chemother Pharmacol 2016 Oct 23;78(4):785-90. Epub 2016 Aug 23.

Department of Obstetrics and Gynecology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-3133-4DOI Listing
October 2016

In Regard to Nagata et al.

Int J Radiat Oncol Biol Phys 2016 07;95(4):1320

Department of Radiology, Koshigaya Municipal Hospital, Koshigaya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.04.005DOI Listing
July 2016

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505.

J Clin Oncol 2015 Jul 2;33(19):2129-35. Epub 2015 Mar 2.

Ryo Kitagawa, NTT Medical Center Tokyo; Taro Shibata, National Cancer Center; Takahiro Kasamatsu, National Cancer Center Hospital, Tokyo; Noriyuki Katsumata, Nippon Medical School, Musashikosugi Hospital, Kanagawa; Toshiharu Kamura and Kimio Ushijima, Kurume University, Fukuoka; Toru Nakanishi, Aichi Cancer Center Hospital, Aichi; Sadako Nishimura, Osaka City General Hospital, Osaka; Masashi Takano, National Defense Medical College, Saitama; and Toyomi Satoh and Hiroyuki Yoshikawa, University of Tsukuba, Ibaraki, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.4391DOI Listing
July 2015

Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer.

J Thorac Oncol 2015 Jul;10(7):1099-106

*Division of Biomedical Statistics and Informatics, Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota; †Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona; ‡Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; §Department of Biostatistics and Bioinformatics, Alliance Statistics and Data Center, Duke University, Durham, North Carolina; ‖Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; ¶Department of Oncology, NCIC Clinical Trials Group, Queen' University, Kingston, ON, Canada; #Department of Hematology & Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia; **Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, California; ††Department of Statistics for the Data Center/Operations Office, Japan Clinical Oncology Group Data Center, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan; ‡‡Department of Medical Oncology, Japanese Society of Medical Oncology, Tokyo, Japan; §§Department of Medicine, The University of Chicago Medicine and Biologic Sciences Center, Chicago, Illinois; and ‖‖Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153349
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000548DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493926PMC
July 2015

Japanese universal health care faces a crisis in cancer treatment.

Lancet Oncol 2015 Mar;16(3):251-2

Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Strategic Planning Bureau, National Cancer Center, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)70007-0DOI Listing
March 2015

Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A).

Gastric Cancer 2014 3;17(3):514-21. Epub 2013 Sep 3.

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2-E2 Yamadaoka, Suita, Osaka, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-013-0294-2DOI Listing
February 2015

Randomized phase III trial comparing weekly docetaxel plus cisplatin versus docetaxel monotherapy every 3 weeks in elderly patients with advanced non-small-cell lung cancer: the intergroup trial JCOG0803/WJOG4307L.

J Clin Oncol 2015 Feb 12;33(6):575-81. Epub 2015 Jan 12.

Tetsuya Abe and Akira Yokoyama, Niigata Cancer Center Hospital, Niigata; Koji Takeda, Osaka City General Hospital; Shinzoh Kudoh, Osaka City University; Shinichiro Nakamura, West Japan Oncology Group Data Center; Kazuhiko Nakagawa, Kinki University, Osaka; Yuichiro Ohe, National Cancer Center Hospital East, Chiba; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Hiroaki Okamoto, Yokohama Municipal Citizens Hospital, Kanagawa; Nobuyuki Yamamoto, Wakayama Medical University School of Medicine, Wakayama; Hiroshige Yoshioka, Kurashiki Central Hospital, Kurashiki; Koichi Minato, Gunma Cancer Center, Gunma; Toshiyuki Sawa, Gifu Municipal Hospital, Gifu; Yasuo Iwamoto, Hiroshima City Hospital, Hiroshima; Hideo Saka, Nagoya Medical Center; Masahiko Ando, Nagoya University Hospital, Aichi; Junki Mizusawa and Taro Shibata, Japan Clincal Oncology Group Data Center, National Cancer Center; Nagahiro Saijo, Japanese Society of Medical Oncology; and Tomohide Tamura, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.8627DOI Listing
February 2015

A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206).

Jpn J Clin Oncol 2014 Apr 27;44(4):379-82. Epub 2014 Jan 27.

*Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyt233DOI Listing
April 2014

Phase III study comparing amrubicin plus cisplatin with irinotecan plus cisplatin in the treatment of extensive-disease small-cell lung cancer: JCOG 0509.

J Clin Oncol 2014 Apr 17;32(12):1262-8. Epub 2014 Mar 17.

Miyako Satouchi, Hyogo Cancer Center, Akashi; Yoshikazu Kotani, Kobe University Graduate School of Medicine, Kobe; Taro Shibata and Haruhiko Fukuda, Japan Clinical Oncology Group Data Center, Multi-Institutional Clinical Trial Support Center, National Cancer Center; Yuichiro Ohe, National Cancer Center Hospital East; Makoto Nishio, Cancer Institute Hospital, Japanese Foundation For Cancer Research; Tomohide Tamura, National Cancer Center Hospital; Nagahiro Saijo, Japanese Society of Medical Oncology, Tokyo; Masahiko Ando, Kyoto University School of Public Health, Kyoto; Kazuhiko Nakagawa, Kinki University School of Medicine; Koji Takeda, Osaka City General Hospital; Tatsuo Kimura, Graduate School of Medicine, Osaka City University; Shinji Atagi, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka; Nobuyuki Yamamoto, Shizuoka Cancer Center, Shizuoka; Yukito Ichinose, National Hospital Organization Kyushu Cancer Center, Fukuoka; Toyoaki Hida, Aichi Cancer Center, Nagoya; Koichi Minato, Gunma Cancer Center, Gunma; and Akira Yokoyama, Niigata Cancer Center Hospital, Niigata, Japan.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.53.5153
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.53.5153DOI Listing
April 2014

Which is the optimal response criteria for evaluating preoperative treatment in esophageal cancer: RECIST or histology?

Ann Surg Oncol 2013 Sep 17;20(9):3009-14. Epub 2013 Mar 17.

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-013-2946-1DOI Listing
September 2013

Watchful waiting versus intravesical BCG therapy for high-grade pT1 bladder cancer with pT0 histology after second transurethral resection: Japan Clinical Oncology Group Study JCOG1019.

Jpn J Clin Oncol 2012 Nov 5;42(11):1094-8. Epub 2012 Sep 5.

Japan Clinical Oncology Group Data Center/Operations Office, Multi-institutional Clinical Trial Support Center, National Cancer Center, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hys143DOI Listing
November 2012

Evaluation of three definitions of progression-free survival in preoperative cancer therapy (JCOG0801-A).

Jpn J Clin Oncol 2012 Oct 27;42(10):896-902. Epub 2012 Jul 27.

Multi-institutional Clinical Trial Support Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hys122DOI Listing
October 2012

A Phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical Stage II/III squamous cell carcinoma of anal canal (JCOG0903: SMART-AC).

Jpn J Clin Oncol 2011 May 5;41(5):713-7. Epub 2011 Apr 5.

Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyr028DOI Listing
May 2011

A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).

Jpn J Clin Oncol 2010 Mar 22;40(3):271-4. Epub 2009 Nov 22.

Department of Thoracic Surgery, Kanagawa Cancer Center, 1-1-2, Nakao, Asahi-ku, Yokohama 241-0815, Japan.

View Article

Download full-text PDF

Source
https://academic.oup.com/jjco/article-lookup/doi/10.1093/jjc
Publisher Site
http://dx.doi.org/10.1093/jjco/hyp156DOI Listing
March 2010

Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study: Japan Clinical Oncology Group study (JCOG 0701).

Jpn J Clin Oncol 2008 May 3;38(5):387-9. Epub 2008 Apr 3.

Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.

View Article

Download full-text PDF

Source
https://academic.oup.com/jjco/article-lookup/doi/10.1093/jjc
Publisher Site
http://dx.doi.org/10.1093/jjco/hyn025DOI Listing
May 2008

Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.

Pathol Res Pract 2006 2;202(10):705-12. Epub 2006 Aug 2.

Breast and Medical Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prp.2006.05.006DOI Listing
November 2006

A meta-analysis of randomized controlled trials of intracoronary gamma- and beta-radiation therapy for in-stent restenosis.

Heart Vessels 2006 Nov 27;21(6):368-74. Epub 2006 Nov 27.

Tokyo Women's Medical University, Shinjuku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00380-006-0919-zDOI Listing
November 2006

Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy.

J Cancer Res Clin Oncol 2006 Oct 22;132(10):635-42. Epub 2006 Jun 22.

Breast and Medical Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-006-0110-zDOI Listing
October 2006

New drug approval times and clinical evidence in Japan.

Contemp Clin Trials 2005 Dec 24;26(6):660-72. Epub 2005 Aug 24.

Faculty of Pharmaceutical Sciences, Kanazawa University, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2005.07.003DOI Listing
December 2005

Successful bridging strategy based on ICH E5 guideline for drugs approved in Japan.

Clin Pharmacol Ther 2005 Aug;78(2):102-13

Pharmaceuticals and Medical Devices Agency and Statistics and Cancer Control Division, National Cancer Center, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clpt.2005.04.001DOI Listing
August 2005

Pharmacokinetic-pharmacodynamic analysis of fluoroquinolones against Bacillus anthracis.

J Infect Chemother 2004 Apr;10(2):97-100

Pharmaceuticals and Medical Devices Evaluation Center, National Institute of Health Sciences, Toranomon 33 Mori Building, 10F, 3-8-21 Toranomon, Minato-ku, Tokyo 105-8409, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10156-004-0303-9DOI Listing
April 2004